Entity Details

Primary name GUCY1A1
Entity type gene
Source Source Link

Details

PrimaryID2982
RefseqGeneNG_034128
SymbolGUCY1A1
Nameguanylate cyclase 1 soluble subunit alpha 1
Chromosome4
Location4q32.1
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-17
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsGCYA1_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004383 guanylate cyclase activity
GO:0005525 GTP binding
GO:0006182 cGMP biosynthetic process
GO:0007263 nitric oxide mediated signal transduction
GO:0008015 blood circulation
GO:0008074 guanylate cyclase complex, soluble
GO:0008217 regulation of blood pressure
GO:0010750 positive regulation of nitric oxide mediated signal transduction
GO:0020037 heme binding
GO:0038023 signaling receptor activity
GO:0060087 relaxation of vascular associated smooth muscle
GO:0098925 retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission
GO:0098978 glutamatergic synapse
GO:0098982 GABA-ergic synapse

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615750 OMIMMoyamoya disease 6 with or without achalasia (MYMY6)A form of Moyamoya disease, a progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. MYMY6 is characterized by severe cerebral angiopathy and onset of severe achalasia in infancy or early childhood. The disease is caused by variants affecting the gene represented in this entry.

Interactions

12 interactions